R.PR
REGISTERED-PRINCIPAL REGISTER
04/21/2026
Back to search
Official data from USPTO
LIXACOL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
12
Latest update
04/21/2026
Trademark type
Word
Nice classes
5
Filing date
04/03/2025
Registration date
04/21/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/21/2026
Last transaction
04/21/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
09
Owner location
CH
Examiner
CLAYTON, CHERYL A
Law office
L20
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Tillotts Pharma AG
Representatives
No representative data.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparationsin particular for the diagnosisprevention and treatment of gastrointestinal disorders and conditions; pharmaceutical preparation for the treatment of inflammation; pharmaceutical preparations containing glucocorticoid steroids; dietetic substances in the nature of oral diagnostic preparations and oral pharmaceutical preparations adapted for medical usein particular for the diagnosisprevention and treatment of gastrointestinal disorders and conditions
Publications
History of USPTO decisions and trademark events.
12 publications found
PUBO
PUBLISHED FOR OPPOSITION
03/03/2026
NPUB
NOTICE OF PUBLICATION
02/25/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/09/2026
RFWR
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
02/07/2026
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/15/2026
CNRT
NON-FINAL ACTION WRITTEN
01/14/2026
DOCK
ASSIGNED TO EXAMINER
08/31/2025
MAFR
APPLICATION FILING RECEIPT MAILED
05/30/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/30/2025
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
05/28/2025
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
05/15/2025
Continuous trademark protection
Get notified about every new filing that threatens LIXACOL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.